Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 251,510 | 540,856 | 578,929 | 1,347,186 | 1,526,606 |
| Marketable Securities | 494,450 | 392,888 | N/A | N/A | N/A |
| Receivables | 106,446 | 108,285 | 297,240 | 82,375 | 454,993 |
| Inventories | 11,545 | 8,749 | 41,696 | 36,683 | 8,872 |
| Other current assets | 87,510 | 0 | 0 | 0 | 0 |
| TOTAL | $978,276 | $1,128,942 | $1,143,888 | $1,703,391 | $2,155,119 |
| Non-Current Assets | |||||
| PPE Net | 44,800 | 138,413 | 305,771 | 294,247 | 225,741 |
| Intangibles | 113,462 | 107,478 | 127,454 | 126,331 | 131,479 |
| Other Non-Current Assets | 39,974 | 185,585 | 220,377 | 134,710 | 64,414 |
| TOTAL | $198,236 | $431,476 | $653,602 | $555,288 | $421,634 |
| Total Assets | $1,176,512 | $1,560,418 | $1,797,490 | $2,258,679 | $2,576,753 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,578 | 41,579 | 132,610 | 216,517 | 127,050 |
| Accrued Expenses | 107,165 | 211,165 | 394,668 | 591,158 | 673,731 |
| Other current liabilities | 185,647 | 219,596 | 861,408 | 930,055 | 36,061 |
| TOTAL | $459,950 | $1,154,416 | $1,635,138 | $2,459,944 | $2,390,319 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 140,053 | 675,067 | 241,310 | 370,137 | 1,422,944 |
| Other Non-Current Liabilities | 483,281 | 529,298 | 201,146 | 222,161 | 365,579 |
| TOTAL | $844,315 | $1,029,843 | $879,279 | $432,813 | $538,107 |
| Total Liabilities | $1,304,265 | $2,184,259 | $2,514,417 | $2,892,757 | $2,928,426 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 162,936 | 160,844 | 139,953 | 86,173 | 76,283 |
| Common Shares | 1,650 | 1,619 | 1,405 | 868 | 764 |
| Retained earnings | -4,568,148 | -5,008,450 | -4,820,951 | -4,275,889 | -3,617,950 |
| Other shareholders' equity | 1,989 | -22,413 | 2,455 | -6,036 | -1,454 |
| TOTAL | $-127,753 | $-623,841 | $-716,927 | $-634,078 | $-351,673 |
| Total Liabilities And Equity | $1,176,512 | $1,560,418 | $1,797,490 | $2,258,679 | $2,576,753 |